Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole.

Toenail tinea is a very recalcitrant dermatosis. Griseofulvin at > or = 500 mg/day is the current medication of choice, but it is minimally successful. In a controlled open trial ultramicrosize griseofulvin (UMSG) at doses of 660 and 990 mg/day was compared with itraconazole at 100 mg/day in 109 pat...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Korting, H C, Schäfer-Korting, M, Zienicke, H, Georgii, A, Ollert, M W
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1993
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192229/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8257124/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.10.2064
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!